Optimal implementation of sodium-glucose cotransporter-2 inhibitors in US patients with heart failure estimated to cause a significant reduction in worsening heart failure events over 3 years
1. In this decision analytical model study among 4.8 million adults with heart failure in the United States, optimal implementation ...